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Dry needling (DN) is an intervention used to address impairments 
in neuromusculoskeletal function related to pain, stiffness, and loss 
of motion. DN incorporates a thin filiform needle which penetrates 
the skin and stimulates underlying myofascial trigger points, 
muscular, and connective tissues for the management of 
neuromusculoskeletal pain and movement impairments.1  
 
Trigger points (TP) are exquisitely tender spots in discrete taut 
bands of hardened muscle that produce local and referred pain. 
These areas of intense focal sarcomere contraction2 are often 
found in postural muscles;3 creating pain, stiffness, and muscle 
dysfunction and interfering with activities such as walking.  
 
DN is associated with decreased pain and improvements in 
flexibility, strength, and performance of activities (such as walking) 
in individuals with trigger points.4  It’s possible that DN modifies the 
mechanical properties of muscle; and thereby reduces pain and 
improves efficiency of muscle.5,6   
 
The purpose of this study was to evaluate the immediate and 
delayed changes in muscle stiffness (in a resting and contracted 
state) related to DN of the gastrocnemius compared to a sham DN 
condition.  To further investigate this relationship, we investigated 
these changes at the site of the TP, as well as at a standard site 
(medial head of the gastrocnemius).  We hypothesize that 
gastrocnemius DN reduces muscle stiffness in individuals with TP.  
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This RCT investigated the immediate and delayed impact of 
gastrocnemius DN or sham DN on muscle stiffness in a resting and 
contracted state.  Stiffness was measured at the TP and standard 
site on the medial gastrocnemius.  
• 1st visit: demographics were collected, participants completed initial 
measures, received randomly assigned intervention (DN or sham), and 
completed post-test measurements. 
• 2nd visit (7-10 days later): participants completed a second post-test of 
the measures, received their second dose of their randomly assigned 
intervention (DN or sham), and completed post-test measurements. 
• 3rd visit (7-10 days later): participants completed final post-test 
measurements.   
 
Figure 1 (Right):  Participant timeline.  The x axis 
represents time, green bar represents consent 
process and collection of demographic data, blue 
bars represent performance of outcome measures, 
and orange bars represent receiving intervention.    
Table 1 (Left):  Outcomes of Muscle Stiffness (MyotonPRO).  Top values represent the control site (medial head of the gastrocnemius) in the resting state.   Top/middle values represent 
the testing site (trigger point in the gastrocnemius) in resting state.  Bottom/middle values represent the control site (medial head of the gastrocnemius) in a contracted state.  Bottom 
values represent the testing site (trigger point in the gastrocnemius) in a contracted state.  Note the significant decrease in resting muscle stiffness immediately after each DN session at 
the trigger point site.   
  SHAM GROUP          DN GROUP GROUP DIFF 
Outcome Visit 
Mean Score + 
SD 
Mean Change From 
Baseline (95% CI) 
Mean Score + 
SD 
Mean Change From 
Baseline (95% CI) 
Mean Difference 
Between Groups in 
Change From 
Baselinea (95% CI) 
P Value 
Medial Head:  Resting Muscle Stiffness of Gastrocnemius  (N/m) 
  
Baseline 
295.6 + 57.7   308.2 + 69.9       
(Day 1 Pre) 
Assessment 1 (Day 1 Post) 294.9 + 60.9 .7 (-5.8, 7.2) 300.6 + 59.1 7.6 (-6.0, 21.2) -5.7 (-38.4, 27.1) 0.73 
Assessment 2 (7-10 days pre) 300.5 + 60.4 -4.9 (-14.9, 5.1) 293.3 + 61.8 14.8 (.9, 28.7)* 7.1 (-26.2, 40.5) 0.67 
Assessment 3 (7-10 days post) 295.8 + 66.2 -.2 (-12.2, 11.8) 287.0 + 52.8 21.1 (6.2, 36.0)* 8.7 (-24.0, 41.4) 0.59 
Assessment 4 (2 Weeks) 290.2 + 53.6 5.4 (-7.9, 18.7) 293.6 + 64.6 14.6 (1.9, 27.2)* -3.4 (-35.8, 29.1) 0.84 
Trigger Point:  Resting Muscle Stiffness of Gastrocnemius  (N/m) 
  
Baseline  
281.4 + 28.6   283.3 + 52.9       
(Day 1 Pre) 
Assessment 1 (Day 1 Post) 275.5 + 51.8 5.9 (-6.4, 18.2) 276.7 + 51.1 6.6 (-.8, 14.0) -1.3 (-29.4, 26.9) 0.93 
Assessment 2 (7-10 days post) 290.5 + 63.2 -9.1 (-29.6, 11.4) 270.4 + 49.7 12.9 (1.4, 24.2)* 20.0 (-11.0, 51.1) 0.2 
Assessment 3 (7-10 days post) 282.6 + 56.1 -1.2 (-18.8, 16.5) 268.0 + 36.1 15.4 (3.9, 26.8)* 14.6 (-11.1, 40.4) 0.26 
Assessment 4 (2 Weeks) 276.3 + 42.8 5.1 (-15.0, 25.2) 290.2 + 52.2 -6.9 (-22.1, 8.3) -13.9 (-40.0, 12.1) 0.29 
Medial Head:  Contracted Muscle Stiffness of Gastrocnemius  (N/m) 
  
Baseline  
507.3 + 208.2   479.1 + 174.9       
(Day 1 Pre) 
Assessment 1 (Day 1 Post) 504.6 + 211.5 2.8 (-13.6, 19.1) 469.7 + 173.5 9.4 (-16.8, 35.6) 34.9 (-70.8, 140.5) 0.51 
Assessment 2 (7-10 days post) 527.4.5 + 237.2 -20.0 (-59.8, 19.7) 471.1 + 166.1 8.0 (-31.0, 46.9) 56.3 (-55.6, 168.1) 0.32 
Assessment 3 (7-10 days post) 531.6 + 233.6 -24.3 (-57.6, 9.1) 453.5 + 156.0 25.6 (-19.6, 70.8) 78.1 (-30.4, 186.6) 0.16 
Assessment 4 (2 Weeks) 485.9 + 207.4 21.4 (-23.4, 66.3) 451.8 + 165.5 27.3 (-7.9, 62.5) 34.1 (-68.3, 136.6) 0.51 
Trigger Point:  Contracted Muscle Stiffness of Gastrocnemius  (N/m) 
  
Baseline  
502.3 + 189.5   465.1 + 141.0       
(Day 1 Pre) 
Assessment 1 (Day 1 Post) 493.9 + 175.9 8.4 (-13.7, 30.5) 445.2 + 146.6 20.0 (1.1, 38.8)* 48.7 (-39.7, 137.1) 0.27 
Assessment 2 (7-10 days post) 551.3 + 228.3 -49.1 (-97.7, -.5)* 463.1 + 130.8 2.0 (-34.7, 38.8) 88.2 (-13.4, 189.8) 0.09 
Assessment 3 (7-10 days post) 526.5 + 215.2 -7.7 (-68.8, 53.4) 473.2 + 118.5 -.1 (-51.7, 51.6) 53.3 (-41.5, 148.2) 0.26 
Assessment 4 (2 Weeks) 482.9 + 179.9 19.4 (-28.6, 67.4) 463.0 + 115.1 2.1 (-32.9, 37.2) 41.1 (-62.6, 102.4) 0.63 
54 individuals were recruited and randomized into either the DN 
or sham group. Baseline characteristics were similar between the 
two groups. No significant adverse events were reported.  
 
A significant group by time interaction was found for resting 
muscle stiffness at the intervention site (TP)  [13.9 N/m (95% CI: -
12.1, 40), P=.03]; but not at the standard site (medial head of the 
gastrocnemius muscle). No other significant group by time 
interactions were found for any other outcome variables.   
 
For the DN group, a significant decrease in resting muscle 
stiffness immediately after each DN session was found [-14.8 N/m 
(95% CI: -28.7, -.9), P=.04], [-21.1 N/m (95% CI: -36.0, -6.2), 
P<.01]. These changes were not maintained at the final visit [-
14.6 N/m (95% CI: -27.2, -1.9), P=.03].   
 
No differences between groups were found for muscle stiffness 
under the contracted condition.   
   
 
Figure 3 (Left):  Post-Testing Trials for Resting Muscle Stiffness at the Trigger point.  The x-axis represent post-
test trial number, y-axis represents stiffness at the trigger point.  The orange line represent changes between 
post-test trials for the participants receiving DN and the blue line represents changes between post-test trials 
for the sham group.  Note the decrease in muscle stiffness for the DN group at post-test trial 2 and 3. 
These results suggest that the DN intervention is associated 
with a reduction in resting muscle stiffness when measured at 
an active trigger point compared to a sham 
condition.  Further, this effect is limited to the site of 
intervention, and not to a standard location within the same 
muscle receiving the intervention. 
 
The increase in resting muscle stiffness at assessment 4 (3rd 
visit) is interesting.  It is possible that the overall 
neuromusculoskeletal system is responding to the multiple 
interventions and recalibrating to the changes in muscle 
stiffness.    
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Figure 2 (Left):  Photograph of dry needling intervention of a trigger point.  Note the demarcation of the 
trigger point with a marker on the medial gastrocnemius.    
Figure 4 (Below):  Photographs of the 
measurement of resting muscle stiffness 
(top) and contracted muscle stiffness 
(bottom). Note demonstration of the 
myotome measuring the standard site. 
Conclusion 
Preliminary findings suggest that DN is associated with a 
reduction in resting muscle stiffness at the trigger point 
compared to a sham condition.  
 
Further data collection (to a sample size of n=102) will further 
elucidate these findings.    
